IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $4,266,000 | -24.2% | 1,236,394 | 0.0% | 8.06% | -7.0% |
Q2 2018 | $5,626,000 | +37.9% | 1,236,394 | 0.0% | 8.66% | +84.6% |
Q1 2018 | $4,080,000 | -15.4% | 1,236,394 | 0.0% | 4.69% | -26.8% |
Q4 2017 | $4,822,000 | -67.0% | 1,236,394 | -12.5% | 6.40% | -56.3% |
Q3 2017 | $14,627,000 | -23.6% | 1,413,280 | -28.0% | 14.65% | -40.1% |
Q2 2017 | $19,137,000 | +43.4% | 1,962,720 | 0.0% | 24.47% | +509.5% |
Q1 2017 | $13,346,000 | +23.6% | 1,962,720 | 0.0% | 4.01% | +31.3% |
Q4 2016 | $10,795,000 | -27.4% | 1,962,720 | 0.0% | 3.06% | -25.4% |
Q3 2016 | $14,877,000 | -7.1% | 1,962,720 | 0.0% | 4.10% | -37.1% |
Q2 2016 | $16,016,000 | -37.2% | 1,962,720 | 0.0% | 6.52% | -34.3% |
Q1 2016 | $25,515,000 | -35.3% | 1,962,720 | 0.0% | 9.91% | +30.3% |
Q4 2015 | $39,411,000 | +64.6% | 1,962,720 | 0.0% | 7.61% | +34.2% |
Q3 2015 | $23,945,000 | -41.6% | 1,962,720 | -1.1% | 5.67% | -32.6% |
Q2 2015 | $40,967,000 | -19.6% | 1,983,858 | -17.8% | 8.41% | -49.4% |
Q1 2015 | $50,960,000 | -38.6% | 2,414,040 | -10.5% | 16.62% | -60.5% |
Q4 2014 | $82,975,000 | – | 2,695,757 | – | 42.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Svennilson Peter | 6,642,942 | $8,636,000 | 7.61% |
Versant Venture Management, LLC | 2,208,210 | $2,870,673,000 | 1.42% |
BVF INC/IL | 5,185,383 | $6,741,000 | 0.88% |
EcoR1 Capital, LLC | 5,603,191 | $7,284,000 | 0.73% |
Abingworth LLP | 352,300 | $458,000 | 0.42% |
Bain Capital Public Equity Management, LLC | 892,061 | $1,160,000 | 0.11% |
ALGERT GLOBAL LLC | 92,591 | $120,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 41,068 | $53,000 | 0.01% |
OXFORD ASSET MANAGEMENT LLP | 136,468 | $177,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 27,122 | $35,000 | 0.01% |